Loading

Annals of Clinical and Experimental Hypertension

Phenotypical Changes of the Pulmonary Artery Endothelial Cells in Fetal Sheep Model of Persistent Pulmonary Hypertension of the Newborn

Review Article | Open Access Volume 3 | Issue 2 |

  • 1. Department of Pediatrics, Medical College of Wisconsin, USA
+ Show More - Show Less
Corresponding Authors
Ru-Jeng Teng, Department of Pediatrics, Medical College of Wisconsin, C410, 999N 92nd Street, Milwaukee, WI 53226, USA, Tel: 414-266-6820;
Abstract

Persistent pulmonary artery hypertension of the newborn is a common lung disorder in neonates affecting one in every 500 live births with high mortality and morbidity rates. Intrauterine ductus arteriosus constriction in fetal sheep is the most commonly used animal model to study this disease entity. In vitro studies using pulmonary artery endothelial cells obtained from this animal model have provided us a lot of important information to understand this disease. Evidence suggests that there is a phenotypical change with pulmonary artery endothelial cells under pulmonary hypertension with increased formation of reactive oxygen species that lead to changes in several signaling pathways. Research using pulmonary artery endothelial cells from this animal model can help us not only to understanding the Pathophysiology of the persistent pulmonary artery hypertension of the newborn but also finding new targets that we can study to treat the disease in human neonates.

Keywords

•    Persistent pulmonary hypertension of the newborn (PPHN)
•    Reactive oxygen species (ROS)
•    Endothelial nitric oxide synthase (eNOS)
•    Apoptosis
•    Autophagy
•    AMP activated protein kinase (AMPK)

Citation

Teng RJ, Wu TJ (2015) Phenotypical Changes of the Pulmonary Artery Endothelial Cells in Fetal Sheep Model of Persistent Pulmonary Hypertension of the Newborn. Ann Clin Exp Hypertension 3(2): 1025.

INTRODUCTION

Persistent pulmonary hypertension of the newborn is a disorder with failure to decrease pulmonary vascular resistance after birth. Persistent pulmonary hypertension of the newborn happens in one out of 500 live births with a mortality rate 10-50%. Right after birth the pulmonary vascular resistance decreases drastically within a few minutes when oxygen enters into the fluid-filled alveoli. Failure to achieve this transition impairs adequate blood flow into the lungs to be oxygenated. There are several mechanisms that can impede this transition such as decreased blood vessel count in the lungs or inadequate production of vasorelaxant by the endothelial cells. The most important vasorelaxants to the pulmonary vasculature are nitric oxide [1] and prostacyclin [2]. Endothelial cells also produce vasoconstricting substance such as endothelin-1. It is believed that the surge of ATP formation by the pulmonary vasculature right after birth is the agonist that prompts the release of nitric oxide and prostacyclin from the pulmonary vasculature [1]. There is evidence to suggest that the productions of nitric oxide and prostacyclin are impaired in persistent pulmonary hypertension of the newborn whereas formation of endothelin-1 is increased. Several animal models have been used to study persistent pulmonary hypertension of the newborn and readers are recommended to read recent reviews [1]. In this short review we only focus on pulmonary artery endothelial cells as the in vitro studies.

Intrauterine ductus arteriosus constriction of fetal sheep as the animal model

Intrauterine ductus arteriosus constriction of fetal sheep at about 80-85% gestation (term=140-145 days) is a commonly used animal model to study persistent pulmonary hypertension of the newborn [3]. After the ductal constriction for 8 days most fetuses will establish severe persistent pulmonary hypertension of the newborn and cannot survive without for more than several hours even with mechanical ventilator support. This animal model has helped us to understand the Pathophysiology of persistent pulmonary hypertension of the newborn and efficacy of using inhalational nitric oxide and prostacyclin analogues in this disease. It was thought the ductal constriction mimics the prenatal exposure to non-steroid anti-inflammatory drugs but studies have shown the physiological changes are more extensive than just increased shear-stress to the pulmonary vasculature.

Increased formation of reactive oxygen species

The most important picture observed from the fetal sheep model of persistent pulmonary hypertension of the newborn is the increased formation of reactive oxygen species in the pulmonary vasculature [4]. Both pulmonary artery endothelial cells [5] and smooth muscle cells from this model show increased reactive oxygen species formation [6]. The increased reactive oxygen species formation impairs the blood vessel formation (angiogenesis) in lungs that contributes to high pulmonary vascular resistance [5]. Poor alveolar formation is also observed in this model (Figure 1). One interesting finding is the pulmonary artery endothelial cells maintain the high reactive oxygen species formation even after multiple passages in vitro indicating a phenotypical change. In vitro studies show antioxidants are capable to improve pulmonary artery endothelial function with persistent pulmonary hypertension of the newborn [5].

Figure 1 Intrauterine ductus arteriosus constriction of fetal sheep produce picture of persistent pulmonary hypertension of the newborn and poor lung development mimicking human disease. Control (left) sheep has better alveolar formation than the co-twin (right) sheep with pulmonary hypertension

Figure 1 Intrauterine ductus arteriosus constriction of fetal sheep produce picture of persistent pulmonary hypertension of the newborn and poor lung development mimicking human disease. Control (left) sheep has better alveolar formation than the co-twin (right) sheep with pulmonary hypertension

Mechanisms of increased reactive oxygen species formation

NADPH oxidase, especially isoform II, has been shown to contribute to the increased reactive oxygen species formation in both cell types [5,6] but other reactive oxygen species forming enzymes/systems have also been shown in pulmonary artery endothelial cells. Endothelial nitric oxide synthase is the enzyme that produces nitric oxide to relax pulmonary arteries but this enzyme requires multiple co-factors including tetrahydrobiopterin. Without tetrahydrobiopterin the endothelial nitric oxide synthase will be uncoupled [7] and forms superoxide instead of nitric oxide as the end product. The superoxide formation will decrease the availability of nitric oxide to the pulmonary artery smooth muscle cells with pulmonary vasoconstriction. GTP cyclohydroplase-1 is the rate limit-limiting enzyme for tetrahydrobiopterin formation. The GTP cyclohydroplase-1 level decreases in pulmonary artery endothelial cells with persistent pulmonary hypertension that contributes to the endothelial nitric oxide synthase uncoupling [8].

Impaired mitochondrial function

Mitochondria are the power plants for cells through oxidative phosphorylation. As the by-product of oxidative phosphorylation superoxide will be formed. At least one percent of oxygen consumed by cell will be converted into superoxide. Although pulmonary artery endothelial cells have low number of mitochondria the organelle remains one of the sources for reactive oxygen species. Mitochondrial bioenergetics is impaired in pulmonary artery endothelial cells with persistent pulmonary hypertension of the newborn.

Mitochondrial manganese superoxide dismutase is the first defense mechanism inside of mitochondria to protect against reactive oxygen species induced injury. The uncoupled endothelial nitric oxide synthase in persistent pulmonary hypertension of the newborn impairs manganese superoxide dismutase transport into mitochondria after its synthesis in cytosol [9] and also decreases manganese superoxide dismutase activity by post-translational nitration [10]. Impaired manganese superoxide dismutase activity leads to decreased ATP formation in pulmonary artery endothelial cells [9].

Decreased AMP-activated protein kinase activity

Decreased ATP formation should activate AMP-activated protein kinase but such mechanism is not achieved in persistent pulmonary hypertension of the newborn pulmonary artery endothelial cells [11]. This unexpected finding indicates there is a Phenotypical change of persistent pulmonary hypertension of the newborn pulmonary artery endothelial cells. Through peroxisome proliferator-activated receptor gamma co activator 1AMP-activated protein kinase promotes mitochondrial biogenesis. The impaired AMP-activated protein kinase signaling contributes to decreased angiogenesis and mitochondrial function, and increased reactive oxygen species formation in persistent pulmonary hypertension of the newborn pulmonary artery endothelial cells. In vitro metformin treatment can activate the AMP-activated kinase in pulmonary artery endothelial cells with persistent pulmonary hypertension of the newborn [11] with increased GTP-chclohydrolase-1 levels and improved endothelial nitric oxide synthase activity.

Endoplasmic reticulum stress and Nogo-B receptor

The functional changes in persistent pulmonary hypertension of the newborn pulmonary artery endothelial cells also involve the endoplasmic reticulum. The increased reactive oxygen species formation can lead to disturbed protein folding and stress to the endoplasmic reticulum. The sustained endoplasmic reticulum stress can further increase reactive oxygen species formation. One of the endoplasmic reticulum proteins, Nogo-B, and its receptor, Nogo-B receptor, has been studied in persistent pulmonary hypertension of the newborn. In adult patient with idiopathic pulmonary hypertension the serum levels of Nogo-B are increased and are believed to aggravate endoplasmic reticulum stress and mitochondrial dysfunction [12]. Nogo-B receptor on the other hand has been shown to mediate angiogenesis via PKB/Akt pathway [13]. The Nogo-B receptor levels decrease in both pulmonary artery endothelial cells and pulmonary artery smooth muscle cells and manipulating Nogo-B receptor level in pulmonary artery endothelial cells affect the angiogenesis in vitro. The exact mechanism by which Nogo-B receptor modulates angiogenesis remains to be explored but GTP cyclohydroplase-1 and mitochondrial biogenesis seems to be involved [14].

Increased autophagy and apoptosis

Pulmonary artery endothelial cells from adult patients with idiopathic pulmonary hypertension are apoptosis-resistant but in persistent pulmonary hypertension of the newborn the pulmonary artery endothelial cells are pro-apoptotic [5]. The increased reactive oxygen species formation is believed to be an important contributing factor to the apoptosis. Apoptosis, necrosis and autophagy are three major types of cell death mechanisms. Autophagy is an adaptive mechanism for cells that facing extreme stressful environment. Autophagy can either anti-death or pro-death depends upon the context. In persistent pulmonary hypertension of the newborn pulmonary artery endothelial cells there is an increased autophagy [15].Contrary to the autophagy in aortic endothelial cell which is needed in angiogenesis [16] the autophagy in persistent pulmonary hypertension of the newborn pulmonary artery endothelial cells is pro-apoptotic. The increased reactive oxygen species formation from NADPH oxidase-2 in persistent pulmonary hypertension of the newborn pulmonary artery endothelial cells seems to enhance autophagy and contributes to the impaired angiogenesis [15].

Impaired prostanoid synthesis

Another signaling pathway that control angiogenesis in the developing lungs is the prostacyclin. Not only the levels of prostacyclin synthase decreased in persistent pulmonary hypertension of the newborn pulmonary artery endothelial cells the uncoupled endothelial nitric oxide synthase in persistent pulmonary hypertension of the newborn pulmonary artery endothelial cells also lead to prostacyclin synthase nitration [17]. The decreased prostacyclin synthase activity explains the decreased prostacyclin production with the precursor shunts to thromboxane A2 formation that either constricts pulmonary arteries or impairs angiogenesis.

CONCLUSION

In conclusion, pulmonary artery endothelial cells in persistent pulmonary hypertension of the newborn show a phenotype with (1) increased reactive oxygen species formation; (2) increased autophagy and apoptosis; (3) impaired prostacyclin and nitric oxide production; (4)impaired AMP-activated protein kinase signaling pathway; (5) decreased Nogo-B receptor expressions; (6) increased endoplasmic reticulum stress; and (7) decreased GTP cyclohydroplase-1 levels and tetrahydrobiopterin formation (Figure 2). All these phenotypical changes lead to impaired angiogenesis which contributes to the increased pulmonary vascular resistance in persistent pulmonary hypertension of the newborn. The increased reactive oxygen species formation also promotes pulmonary artery smooth muscle cells proliferation that is the other path gnomonic finding in persistent pulmonary hypertension of the newborn. Understanding of these newly described phenomena can help us to develop new therapeutic strategies in managing persistent pulmonary hypertension of the newborn.

Figure 2 Summary of the phenotypic changes in pulmonary artery endothelial cells with persistent pulmonary hypertension of the newborn.

Figure 2 Summary of the phenotypic changes in pulmonary artery endothelial cells with persistent pulmonary hypertension of the newborn.

REFERENCES

1. Teng RJ, Wu TJ. Persistent pulmonary hypertension of the newborn. J Formos Med Assoc. 2013; 112: 177-184.

2. Mahajan CN, Afolayan AJ, Eis A, Teng R-J, Konduri GG. Altered prostanoid metabolism contributes to impaired angiogenesis in persistent pulmonary hypertension in a fetal lamb model. Pediatr Res 2015; 77:455-462.

3. Morin FC 3rd. Ligating the ductus arteriosus before birth causes persistent pulmonary hypertension in the newborn lamb. Pediatr Res. 1989; 25: 245-250.

4. Konduri GG, Bakhutashvili I, Eis A, Pritchard K Jr. Oxidant stress from uncoupled nitric oxide synthase impairs vasodilation in fetal lambs with persistent pulmonary hypertension. Am J Physiol Heart Circ Physiol. 2007; 292: H1812-1820.

5. Teng RJ, Eis A, Bakhutashvili I, Arul N, Konduri GG. Increased superoxide production contributes to the impaired angiogenesis of fetal pulmonary arteries with in utero pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2009; 297: L184-L195.

6. Wedgwood S, Lakshminrusimha S, Czech L, Schumacker PT, Steinhorn RH. Increased p22phox/Nox4 expression is involved in remodeling through hydrogen peroxide signaling in experimental persistent pulmonary hypertension of the newborn. Antioxid Redox Signal. 2013; 18: 1765-76.

7. List BM, Klosch B, Volker C, Gorren ACF, Sessa WC, Werner ER, et al. Characterization of bovine endothelial nitric oxide synthase as a homodimer with down-regulated uncoupled NADPH oxidase activity: tetrahydrobiopterin binding kinetics and role of haem in dimerization. Biochem J 1997; 323: 159-165.

8. Konduri GG, Ou J, Shi Y, Pritchard KA Jr. Decreased association of HSP90 impairs endothelial nitric oxide synthase in fetal lambs with persistent pulmonary hypertension. Am J Physiol Heart Circ Physiol. 2003; 285: H204-211.

9. Afolayan AJ, Teng RJ, Eis A, Rana U, Broniowska KA, Corbett JA, et al. Inducible HSP70 regulates superoxide dismutase-2 and mitochondrial oxidative stress in the endothelial cells from developing lungs. Am J Physiol Lung Cell Mol Physiol. 2014; 306: L351-360.

10. Afolayan AJ, Eis A, Teng R-J, Bakhutashvili I, Kaul S, Davis JM, et al. Down regulation of manganese superoxide dismutase activity and expression contributes to oxidative stress in persistent pulmonary hypertension of the newborn. Am J Physiol Lung Cell Mol Physiol, 2012; 303: L870-L879.

11. Teng RJ, Du J, Afolayan AJ, Eis A, Shi Y, Konduri GG. AMP kinase activation improves angiogenesis in pulmonary artery endothelial cells with in utero pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2013; 304: L29-42.

12. Sutendra G, Dromparis P, Wright P, Bonnet S, Haromy A, Hao Z, et al. The role of Nogo and the mitochondria-endoplasmic reticulum unit in pulmonary hypertension. Sci Transl Med. 2011; 3: 88ra55.

13. Zhao B, Chun C, Liu Z, Horswill MA, Pramanik K, Wilkinson GA, et al. Nogo-B receptor is essential for angiogenesis in zebrafish via Akt pathway. Blood. 2010; 116: 5423-5433.

14. Teng RJ, Rana U, Afolayan AJ, Zhao B, Miao QR, Konduri GG. Nogo-B receptor modulates angiogenesis response of pulmonary artery endothelial cells through eNOS coupling. Am J Respir Cell Mol Biol. 2014; 51: 169-177.

15. Teng R-J, Du J, Welak S, Guan T, Eis A, Shi Y, et al. Cross-talk between NADPH oxidase and autophagy in pulmonary artery endothelial cells with intrauterine persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2012; 302:L651-L663.

16. Du J, Teng RJ, Guan T, Eis A, Kaul S, Konduri GG, et al. Role of autophagy in angiogenesis in aortic endothelial cells. Am J Physiol Cell Physiol. 2012; 302: C383-391.

17. Mahajan CN, Afolayan AJ, Eis A, Teng RJ, Konduri GG. Altered prostanoid metabolism contributes to impaired angiogenesis in persistent pulmonary hypertension in a fetal lamb model. Pediatr Res. 2015; 77: 455-462.

Cite this article: Teng RJ, Wu TJ (2015) Phenotypical Changes of the Pulmonary Artery Endothelial Cells in Fetal Sheep Model of Persistent Pulmonary Hypertension of the Newborn. Ann Clin Exp Hypertension 3(2): 1025.

Received : 12 Mar 2015
Accepted : 30 Mar 2015
Published : 31 Mar 2015
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X